Molecular Analysis Of Bladder Cancer
NCT00871754 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2026-01-07
Summary
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.
Conditions
- Bladder Cancer
- Bladder Neoplasms
Sponsors & Collaborators
-
Lahey Clinic
lead OTHER
Principal Investigators
-
Kim Reiger-Christ, PhD · Lahey Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1988-04-30
- Primary Completion
- 2028-12-31
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma
NCT02700464 ·Status: COMPLETED ·Phase: NA
-
Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma
NCT02647112 ·Status: COMPLETED ·Phase: NA
-
A Diagnostic for the Early Detection of Bladder Cancer
NCT05347342 ·Status: ACTIVE_NOT_RECRUITING
-
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
NCT02379429 ·Status: RECRUITING
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Development of a Non-Invasive DNA Methylation-Based Assay System for the Risk Assessment of Urothelial Carcinoma
NCT00867620 ·Status: UNKNOWN
-
Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
NCT05982561 ·Status: RECRUITING
-
Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool
NCT06878027 ·Status: RECRUITING
-
Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
NCT05037279 ·Status: RECRUITING ·Phase: PHASE3
-
The Cxbladder Monitoring Study
NCT02700659 ·Status: COMPLETED
-
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Tissues From Egyptian Male Patients and Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Cancer.
NCT06289270 ·Status: RECRUITING
-
NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.
NCT00318266 ·Status: COMPLETED
-
Urine Cytology and Utility in Bladder Recurrence
NCT00971256 ·Status: COMPLETED
-
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
NCT06289283 ·Status: ACTIVE_NOT_RECRUITING
-
Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
NCT01731652 ·Status: COMPLETED ·Phase: PHASE2
-
Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)
NCT07029256 ·Status: RECRUITING
-
Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria
NCT05362539 ·Status: COMPLETED ·Phase: NA
-
Microscopic-spectroscopic Examination for Urothelial Tissue Characterization
NCT04310813 ·Status: COMPLETED
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer
NCT01738815 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
NCT01373294 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health
NCT00776178 ·Status: COMPLETED
-
Molecular Biosensors for Detection of Bladder Cancer
NCT02957370 ·Status: UNKNOWN
-
Bladder Cancer Screening Trial
NCT05646485 ·Status: RECRUITING ·Phase: NA
-
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
NCT05327647 ·Status: RECRUITING ·Phase: PHASE2